Indian Journal of Community Medicine

: 2014  |  Volume : 39  |  Issue : 4  |  Page : 252--253

Association of overweight and obesity with breast cancer in India: Scope for improvement

Sushama Subhash Thakre1, Subhash Bapuraoji Thakre2,  
1 Associate Professor, Community Medicine, Indira Gandhi Government Medical College, Nagpur, MS, India
2 Associate Professor, Community Medicine, Government Medical College, Nagpur, MS, India

Correspondence Address:
Sushama Subhash Thakre
Associate Professor, Community Medicine, Indira Gandhi Government Medical College, Nagpur, MS

How to cite this article:
Thakre SS, Thakre SB. Association of overweight and obesity with breast cancer in India: Scope for improvement.Indian J Community Med 2014;39:252-253

How to cite this URL:
Thakre SS, Thakre SB. Association of overweight and obesity with breast cancer in India: Scope for improvement. Indian J Community Med [serial online] 2014 [cited 2021 Sep 20 ];39:252-253
Available from:

Full Text


A case-control study which was carried out by Singh et al., [1] titled "Association of overweight and obesity with breast cancer in India." It was concluded that overweight and obese women had odd's ratio of 1.06 and 2.27, respectively, as compared with women with normal weight. Obesity is a well-known risk factor for postmenopausal breast cancer. Numerous epidemiologic studies have reported positive associations between obesity and breast cancer risk among East Asian women. [2],[3],[4],[5] Objective of this article is to address some limitations that should be considered when interpreting their results of case-control study.

Some of the notions by Kenneth and David [6] guide investigators who do or readers who assess case-control study. First, in the present study authors have explicitly defined the criteria for diagnosis of a case of breast cancer but not very clear about geographic distribution of cases. However, this is an important eligibility criteria used for selection of cases. Second control should come from same population as the cases and their selection should be independent of the exposure of the interest. In the present study, it is documented that 320 normal healthy individuals accompanying the patients in the Department of Gastroenterology, Medicine and Surgery at All India Institute of Medical Sciences, New Delhi, and at Comprehensive Rural Health Services Project at Ballabgarh Hospital, Faridabad, Haryana, constituted the control group. In this study, it is not very clear about criteria used for labeling any individual healthy or free from breast cancer. Third, investigators should blind the data gathers to the case or control status of participants or, if impossible, at least blind them to the main hypothesis of the study. To overcome biases, it is necessary to use some blinding technique. Authors failed to address confounding in this study at design stage. It also reveals that care of confounding can be taken care with analytical techniques; there were no paired data in the present study; however, paired "t" test was utilized. It point out that care of confounders can be taken care with proper analytical techniques such as logistic regression analysis or stratified analysis such as Mantel-Haenszel approaches. [6]

Devotions of meticulous attention to these points enhance the validity of the results and bolster the reader's confidence in the findings. This issue needs to be address and optimum precaution to be taken while selecting controls.

As a reader if I assess, I find only comparative information. I do not find adequate discussion about obesity and carcinogenesis. This is very important as a reader's point of view. As the basis for understanding the potential mechanism of obesity and cancer relationship has advanced, numbers of new hypotheses have emerged. The adipocytokines are a complex group of biologically active polypeptides. [7],[8]

Leptin is a growth hormone, secreted by adipose tissue, whose levels are normally elevated in obese individuals and may have a promoting effect on carcinogenesis and metastasis of breast cancer, possibly in an autocrine manner. [9],[10]

This study has some limitations that should be considered when interpreting their results. First, because they did not have updated information on menopausal status, which would modify the association between body mass index/weight change and breast cancer, the possibility of misclassification of menopausal status at breast cancer onset should be considered. Such misclassification would be problematic in premenopausal women, since recently menopausal women would be misclassified as premenopausal during the follow-up period. Such misclassification could partly explain the inconsistent results from several studies of the association between body size and breast cancer among premenopausal women. Studies of younger women with updated information on menopausal status should be initiated among premenopausal women. However, this limitation is a minor concern for postmenopausal women.


1Singh P, Kapil U, Shukla N, Deo SV, Diwedi S. Association of overweight and obesity with breast cancer in India. Indian J Community Med 2011;36:259-62.
2Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, Kuroishi T, et al. Effect of body size on breast-cancer risk among Japanese women. Int J Cancer 1999;80:349-55.
3Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, et al. Obesity and risk of cancer in Japan. Int J Cancer 2005;113:148-57.
4Song YM, Sung J, Ha M. Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 2008;26:3395-402.
5Suzuki R, Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, et al. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status - the Japan Public Health Center-based prospective study. Int J Cancer 2011;129:1214-24.
6Kenneth FS, David AG. The Lancet. The Lancet Handbook of Essential Concepts In Clinical Research. Philadelphia: Elsevier Heidi Harrison; 2006. p. 55-65.
7Kaur T, Zhang ZF. Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev 2005;6:547-52.
8Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153-65.
9Somasundaram P, McFadden DW, Hileman SM, Vona-Davis L. Leptin is a growth factor in cancer. J Surg Res 2004;116:337-49.
10Thomas T, Burgera B, Melton LJ 3 rd , Atkinson EJ, O'Fallon WM, Riggs BL, et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000;49:1278-84.